tradmap

AUPH Earnings Aurinia Pharmaceuticals Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
-$1 $0 $2 $0 2019 2020 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $142M $283M 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$181M $53M $287M $0 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$0 $1 $2 $0 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
EPS
Revenue (quarterly)
$0 $42M $84M Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue
Net income (quarterly)
-$27M $92M $211M $0 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Net income

Reported EPS history

1–34 of 34
Q3 20262026-09-300.232026-10-3010-Q
Q2 20262026-06-300.282026-08-0610-Q
Q1 20262026-03-310.252026-05-0710-Q
Q4 20252025-12-311.532026-02-2610-K
FY 20252025-12-312.072026-02-2610-K
Q3 20252025-09-300.232025-11-0410-Q
Q2 20252025-06-300.162025-07-3110-Q
Q1 20252025-03-310.162025-05-1210-Q
Q4 20242024-12-310.012025-02-2710-K
FY 20242024-12-310.042025-02-2710-K
Q3 20242024-09-300.102024-11-0710-Q
Q2 20242024-06-300.012024-08-0110-Q
Q1 20242024-03-31-0.072024-05-0210-Q
Q4 20232023-12-31-0.192024-02-1510-K
FY 20232023-12-31-0.542024-02-1510-K
Q3 20232023-09-30-0.092023-11-0210-Q
Q2 20232023-06-30-0.082023-08-0310-Q
Q1 20232023-03-31-0.182023-05-0410-Q
Q4 20222022-12-31-0.182023-02-2810-K
FY 20222022-12-31-0.762023-02-2810-K
Q3 20222022-09-30-0.062022-11-0310-Q
Q2 20222022-06-30-0.252022-08-0410-Q
Q1 20222022-03-31-0.272022-05-1010-Q
Q4 20212021-12-31-0.252022-02-2810-K
FY 20212021-12-31-1.402022-02-2810-K
Q3 20212021-09-30-0.392021-11-0310-Q
Q2 20212021-06-30-0.372021-08-0510-Q
Q1 20212021-03-31-0.40——
Q4 20202020-12-31-0.06——
FY 20202020-12-31-0.87——
Q3 20202020-09-30-0.34——
Q2 20202020-06-30-0.24——
Q1 20202020-03-31-0.23——
FY 20192019-12-31-0.95——

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.